These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12952211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA, Moore RL, Evans RD, Hayward RD, Jones BM.
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [Abstract] [Full Text] [Related]

  • 3. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU, Spivak RM, Nah HD, Kirschner RE.
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [Abstract] [Full Text] [Related]

  • 4. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR, Sertié AL, Richieri-Costa A, Alonso LG, Zatz M, Alonso N, Brunoni D, Ribeiro SF.
    Am J Med Genet; 1998 Jul 07; 78(3):237-41. PubMed ID: 9677057
    [Abstract] [Full Text] [Related]

  • 5. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A, Bellosta P, Sahni M, Basilico C.
    J Cell Biol; 2000 Jun 12; 149(6):1297-308. PubMed ID: 10851026
    [Abstract] [Full Text] [Related]

  • 6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, Yang J, Jin M, Deng C, Chen L.
    Bone; 2008 Apr 12; 42(4):631-43. PubMed ID: 18242159
    [Abstract] [Full Text] [Related]

  • 7. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
    Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD.
    Bone; 2005 Feb 12; 36(2):254-66. PubMed ID: 15780951
    [Abstract] [Full Text] [Related]

  • 8. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
    Suzuki H, Suda N, Shiga M, Kobayashi Y, Nakamura M, Iseki S, Moriyama K.
    J Cell Physiol; 2012 Sep 12; 227(9):3267-77. PubMed ID: 22105374
    [Abstract] [Full Text] [Related]

  • 9. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
    van Ravenswaaij-Arts CM, van den Ouweland AM, Hoogeboom AJ, Herbergs J, Pals G.
    Ned Tijdschr Geneeskd; 2002 Jan 12; 146(2):63-6. PubMed ID: 11820058
    [Abstract] [Full Text] [Related]

  • 10. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
    Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C.
    J Cell Biol; 2005 Mar 28; 168(7):1065-76. PubMed ID: 15781477
    [Abstract] [Full Text] [Related]

  • 11. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
    Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ.
    J Clin Invest; 1998 Mar 15; 101(6):1310-7. PubMed ID: 9502772
    [Abstract] [Full Text] [Related]

  • 12. Induction of chondrogenesis in neural crest cells by mutant fibroblast growth factor receptors.
    Petiot A, Ferretti P, Copp AJ, Chan CT.
    Dev Dyn; 2002 Jun 15; 224(2):210-21. PubMed ID: 12112473
    [Abstract] [Full Text] [Related]

  • 13. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
    Lemonnier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ.
    Exp Cell Res; 2000 Apr 10; 256(1):158-67. PubMed ID: 10739663
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
    Ignelzi MA, Wang W, Young AT.
    J Bone Miner Res; 2003 Apr 10; 18(4):751-9. PubMed ID: 12674336
    [Abstract] [Full Text] [Related]

  • 15. Signalling via type IA and type IB bone morphogenetic protein receptors (BMPR) regulates intramembranous bone formation, chondrogenesis and feather formation in the chicken embryo.
    Ashique AM, Fu K, Richman JM.
    Int J Dev Biol; 2002 Mar 10; 46(2):243-53. PubMed ID: 11934153
    [Abstract] [Full Text] [Related]

  • 16. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
    Lemonnier J, Haÿ E, Delannoy P, Lomri A, Modrowski D, Caverzasio J, Marie PJ.
    J Bone Miner Res; 2001 May 10; 16(5):832-45. PubMed ID: 11341328
    [Abstract] [Full Text] [Related]

  • 17. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
    Tanimoto Y, Yokozeki M, Hiura K, Matsumoto K, Nakanishi H, Matsumoto T, Marie PJ, Moriyama K.
    J Biol Chem; 2004 Oct 29; 279(44):45926-34. PubMed ID: 15310757
    [Abstract] [Full Text] [Related]

  • 18. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J, Park OJ, Yoon WJ, Kim HJ, Choi KY, Cho TJ, Ryoo HM.
    J Cell Biochem; 2012 Feb 29; 113(2):457-64. PubMed ID: 21928350
    [Abstract] [Full Text] [Related]

  • 19. Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2.
    Mangasarian K, Li Y, Mansukhani A, Basilico C.
    J Cell Physiol; 1997 Jul 29; 172(1):117-25. PubMed ID: 9207932
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.